Atlas Trials

Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)

Clinical trial NCT02907177 · TERMINATED

Trial details

NCT number
NCT02907177
Sponsor
Actelion
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2017-03-30
Primary completion
2020-03-26
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.